Effects of big endothelin-1 in comparison with endothelin-1 on the microvascular blood flow velocity and diameter of rat mesentery in vivo

Microvascular Research

Volumn 72, Issue 3, 2006, Pages 108-112

  Abdelhalim, Mohamed Anwar K ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Big endothelin 1; Blood flow velocity; Endothelin 1; Intravital microscope system; Microcirculation; Phosphoramidon; Rat mesentery

Indexed keywords

BIG ENDOTHELIN 1; ENDOTHELIN 1; PHOSPHORAMIDON; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTERIOLE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD VESSEL DIAMETER; CATHETERIZATION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; IN VIVO STUDY; JUGULAR VEIN; MESENTERIC ARTERY; MESENTERY BLOOD FLOW; MICROCIRCULATION; MICROSCOPY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC CIRCULATION; VENULE;

SUIDAE;

EID: 33750610789     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2006.04.007     Document Type: Article

References (20)

1. Cernacek P., and Stewart D.J. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem. Biophys. Res. Commun. 161 (1989) 562-567
2. Ergul A., Grubbs A.L., Zhang Y., and Spinale F.G. Selective upregulation of endothelin converting enzyme-1a in the human failing heart. J. Card. Fail. 6 (2000) 314-320
3. Fortes Z.B., De Nucci G., and Garcia-Leme J. Effect of endothelin-1 on arterioles and venules in vivo. J. Cardiovasc. Pharmacol. 13 (1989) S200-S201
4. Fujita K., Matsumura Y., Kita S., Hisaki K., Takaoka M., and Morimoto S. Intrarenal conversion of big endothelin-1 to endothelin-1 in the rat. Life Sci. 55 16 (2002) 1285-1291
5. Fukuroda T., Noguchi K., Tsuchida S., Nishikibe M., Ikemoto F., Okada K., and Yano M. Inhibition of biological actions of big endothelin-1 by phosphoramidon. Biochem. Biophys. Res. Commun. 172 (1990) 390-395
6. Hisaki K., Matsumura Y., Ikegawa R., Nishiguchi S., Hayashi K., Takaoka M., and Morimoto S. Evidence for phosphoramidon-sensitive conversion of big endothelin-1 to endothelin-1 in isolated rat mesenteric artery. Biochem. Biophys. Res. Commun. 177 (1991) 1127-1132
7. Hisaki K., Matsumura Y., Fujita K., Maekawa H., Takaoka M., and Mrimoto S. Differences in potency of big endothelin-1 induced pressor action in rat isolated perfused mesenteric artery, hindquarter and lung. Life Sci. 54 (2002) 275-280
8. Homma S., Miyauchi T., Goto K., Sugishita Y., Sato M., and Ohshima N. Effects of endothelin-1 on coronary microcirculation in isolated beating hearts of rats. J. Cardiovasc. Pharmacol. 17 (1991) S276-S278
9. Ikegawa R., Matsumura Y., Tsukahara Y., Takaoka M., and Morimoto S. Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme. Biochem. Biophys. Res. Commun. 171 (1990) 669-675
10. Koller A., and Kaley G. Endothelium regulates skeletal muscle microcirculation by a blood flow velocity-sensing mechanism. Am. J. Physiol. Heart Circ. Physiol. 258 (1990) H916-H920
11. Kyunghye A., Herman S.B., and Fahnoe D.C. Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity. Arch. Biochem. Biophys. 359 (1998) 258-268
12. Lawrence E., and Brain S.D. Big endothelin-1 and big endothelin-3 are constrictor agents in the microvasculature: evidence for the local phosphoramidon-sensitive conversion of big endothelin-1. Eur. J. Pharmacol. 233 (2002) 243-250
13. McMahon E.G., Palomo M.A., Moore W.M., McDonald J.F., and Stern M.K. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 703-707
14. Miyauchi T., Suzuki N., Kurihara T., Yamaguchi I., Sugishita Y., Matsumoto H., Goto K., and Masaki T. Endothelin-1 and endothelin-3 play different roles in acute and chronic alterations of blood pressure in patients with chronic hemodialysis. Biochem. Biophys. Res. Commun. 178 (1991) 276-281
15. Saito Y., Nakao K., Mukoyama M., and Imura H. Increased plasma endothelin level in patients with essential hypertension. N. Engl. J. Med. 322 (1990) 205
16. Sato M., and Ohshima N. Velocity profiles of blood flow in microvessels measured by ten channels' dual-sensor method. Biorheology 25 (1988) 279-288
17. Schilling L., Vatter H., Mursch K., Ehrenreich H., and Schmiedek P. Characterization of the contractile and relaxant action of the endothelin-1 precursor, big endothelin-1, in the isolated rat basilar artery. Peptides 21 (2000) 91-99
18. Slomiany B.L., Piotrowski J., and Slomiany A. Suppression of endothelin-converting enzyme-1 during buccal mucosal ulcer healing: effect of chronic alcohol ingestion. Biochem. Biophys. Res. Commun. 271 (2000) 318-322
19. Yanagisawa M., and Masaki T. Endothelin, a novel endothelium-derived peptide. Pharmacological activities, regulation and possible roles in cardiovascular control. Biochem. Pharmacol. 38 (1989) 1877-1883
20. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Goto K., Masaki T., and Yazaki Y. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415